AI Article Synopsis

  • The study aimed to evaluate the effectiveness and safety of the NuVent™ EM Balloon Sinus Dilation System in patients undergoing revision sinus surgery due to chronic rhinosinusitis (CRS).
  • A total of 51 adults were enrolled across six clinical sites, with the device successfully navigating and dilating sinus ostia in all cases, treating a total of 121 sinuses without any device-related adverse events.
  • The results indicate that the balloon dilation technique is safe and effective for revising frontal, maxillary, or sphenoid sinus surgeries, as there were no complications directly linked to the device used.

Article Abstract

Purpose: Assess if a rigid, image-guided balloon could be used effectively and safely in revision sinus surgery.

Materials And Methods: A prospective, non-randomized, single-arm, multicenter study to assess the safety and device performance of the NuVent™ EM Balloon Sinus Dilation System. Adults with CRS in need of revision sinus surgery were enrolled for balloon sinus dilation of a frontal, sphenoid, or maxillary sinus. The primary device performance endpoint was the ability of the device to (1) navigate to; and (2) dilate tissue in subjects with scarred, granulated, or previously surgically-altered tissue (revision). Safety outcomes included the assessment of any operative adverse events (AEs) directly attributable to the device or for which direct cause could not be determined. A follow-up endoscopy was conducted at 14 days post-treatment for assessment of any AEs. Performance outcomes included the surgeon's ability to reach the target sinus (es) and dilate the ostia. Endoscopic photos were captured for each treated sinus pre- and post-dilation.

Results: At 6 US clinical sites, 51 subjects were enrolled; 1 subject withdrew before treatment due to a cardiac complication from anesthesia. 121 sinuses were treated in 50 subjects. The device performed as expected in 100 % of the 121 treated sinuses, with investigators able to navigate to the treatment area and dilate the sinus ostium without difficulty. Ten AEs were seen in 9 subjects, with 0 related to the device.

Conclusion: The targeted frontal, maxillary or sphenoid sinus ostium were safely dilated in every revision subject treated, with no AEs directly attributed to the device.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjoto.2023.103803DOI Listing

Publication Analysis

Top Keywords

sinus ostium
12
revision sinus
12
sinus
11
sinus surgery
8
device performance
8
balloon sinus
8
sinus dilation
8
outcomes included
8
aes directly
8
device
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!